Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers
Authors:
- Ming KongMKMing Kong
- Chao FengCFChao Feng
- Kui Kun YangKYKui Kun Yang
- Yang LiYLYang Li
- Jing SuJSJing Su
- Xiao Jie ChengXCXiao Jie Cheng
- Hyun Jin ParkHPHyun Jin Park
- Xi Guang ChenXCXi Guang Chen
- 1 March 2013
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 103, 345-353
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosaInternational Journal of Pharmaceutics, 2011
- Preparation, characterization, and tissue distribution in mice of lactosaminated carboxymethyl chitosan nanoparticlesCarbohydrate Polymers, 2011
- In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine: Nanotechnology, Biology and Medicine, 2010
- In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin deliveryBiomaterials, 2009
- Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of ratsInternational Journal of Pharmaceutics, 2007
- Toxic Potential of Materials at the NanolevelScience, 2006
- Oral peptide and protein delivery: unfulfilled promises?Drug Discovery Today, 2003
- Biodegradable polymeric nanoparticles as drug delivery devicesJournal of Controlled Release, 2001
- Oral insulin delivery1Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin.1Advanced Drug Delivery Reviews, 1999
- Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug deliveryInternational Journal of Pharmaceutics, 1995